文献速递妇产影像儿科影像US

正常与异常妊娠胎儿胰腺超声评估:叙述性综述

Ultrasound Assessment of the Fetal Pancreas in Normal and Abnormal Pregnancies: A Narrative Review.
PubMed 文献 · J Ultrasound Med · 2026-06-29

本综述汇总了利用超声评估胎儿胰腺大小、形态及回声的研究,覆盖正常妊娠及糖尿病、生长受限等高危妊娠。研究显示胰腺测量自孕中期起可重复性良好,且与孕周、腹围及估测胎儿体重密切相关。作者建议在统一方案、多中心验证及长期代谢随访完善后,方可将胰腺参数纳入常规产前风险分层。

要点

  • 胎儿胰腺径线与回声可反映宫内代谢环境改变,阅片时应关注胰腺区域。
  • 糖尿病妊娠中胰腺增大及回声增强与母体血糖负荷相关,需警惕胎儿过度生长。
  • 晚发型生长受限胎儿多数胰腺偏小,胰腺测量有助于辅助识别低出生体重风险。

核心结论

  • 胎儿胰腺的标准化超声评估具有可行性且能提供常规生物测量的补充信息,可反映胎儿对糖尿病暴露、生长受限及综合征性疾病的应答。
  • 需统一测量方案、开展多中心验证并完成长期代谢随访后,胰腺相关参数才可整合入常规产前风险分层。

研究设计与样本

  • 叙述性综述,通过电子数据库检索人类研究,纳入报告胎儿胰腺超声评估的文献。
  • 纳入指标包括胰腺周长、直径、面积、节段长度、衍生比值及回声分级,并与母体代谢状态、胎儿生长和围产结局关联分析。
  • 因研究方法存在异质性,采用基于主题的定性综合方法进行汇总。

关键影像表现/征象

  • 胎儿胰腺大小与回声改变可见于母体糖尿病、胎儿生长受限及结构/遗传性胰腺异常。
  • 糖尿病妊娠中胰腺表现为增大及回声增强,与母体血糖负荷水平相关。
  • 多数已确诊的晚发型胎儿生长受限表现为胰腺径线减小。

诊断标准与关键数值

  • 胎儿胰腺测量自孕中期起可重复获取,与孕龄、腹围及估测胎儿体重具有强相关性。
  • 孕中期胰腺测量值及回声分级对早期妊娠期糖尿病预测表现不一但具一定价值。
  • 基于直径的新型比值可能更早识别低出生体重风险。

临床应用与阅片要点

  • 胎儿胰腺评估可作为常规胎儿生物测量的辅助手段,提供宫内代谢适应信息。
  • 在母体血糖代谢异常或胎儿生长偏离预期的病例中,可尝试观察胰腺大小与回声。
  • 针对胎儿胰腺的定向影像有助于诊断结构性及遗传性胰腺异常。

局限性

  • 纳入研究的方法学异质性限制了定量合并分析。
  • 尚缺乏统一测量方案与多中心验证,不宜直接用于常规产前风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Fetal pancreatic development is central to intrauterine glucose-insulin homeostasis and may influence lifelong metabolic risk. Advances in obstetric ultrasonography now allow in-utero assessment of pancreatic size, morphology, and echotexture, offering a non-invasive window into fetal metabolic adaptation across normal and high-risk pregnancies. A narrative review was conducted using electronic databases to identify human studies reporting sonographic evaluation of the fetal pancreas, including measurements of circumference, diameter, area, segmental lengths, derived ratios, and echogenicity grading, in relation to maternal metabolic status, fetal growth, and perinatal outcomes. Given methodological heterogeneity, a qualitative, theme-based synthesis was performed. Studies demonstrate that pancreatic biometry can be obtained reproducibly from mid-gestation, with strong correlations to gestational age, abdominal circumference, and estimated fetal weight. In diabetic pregnancies, pancreas size and echogenicity increase with maternal glycemic burden and are associated with fetal overgrowth and adverse neonatal outcomes. Mid-trimester pancreatic measurements and echogenicity show variable but promising performance for early gestational diabetes prediction. In contrast, most fetuses with established late-onset fetal growth restriction exhibit reduced pancreatic size, whereas novel diameter-based ratios may identify low-birthweight risk earlier. Targeted imaging aids diagnosis of structural and genetic pancreatic anomalies. Standardized ultrasound assessment of the fetal pancreas has evolved into a feasible, clinically informative adjunct to conventional biometry, reflecting the fetal response to diabetic exposure, growth restriction, and syndromic disease. Harmonized protocols, multicenter validation, and long-term metabolic follow-up are needed before pancreas-based parameters can be incorporated into routine prenatal risk stratification.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Golbasi. Ultrasound Assessment of the Fetal Pancreas in Normal and Abnormal Pregnancies: A Narrative Review. J Ultrasound Med. 2026. PMID: 42373561. doi:10.1002/jum.70357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。